Raleigh pharma raising $122M to prep for potential commercialization

//Raleigh pharma raising $122M to prep for potential commercialization

Raleigh pharma raising $122M to prep for potential commercialization

A Raleigh company developing a COPD treatment is raising more than $100 million as it moves closer to seeking regulatory approval.

Article by [author-name] (c) Banking & Financial News - Banking & Financial News Headlines | Bizjournals.com - Read full story here.

By | 2022-08-14T15:32:35+00:00 August 14th, 2022|Economics|

About the Author: